At the 2023 Lymphoma, Leukemia & Myeloma Congress in New York, Joseph Mikhael, MD, MEd, FRCPC, FACP, Translational Genomics Research Institute, City of Hope Cancer Center, Phoenix, Arizona, argued in favor of minimal residual disease (MRD) testing for patients with multiple myeloma, in both a research setting and in clinical practice.
Benefits of MRD Testing for the Treatment of Patients With Multiple Myeloma
All Press
Make an Appointment
Related Articles
[dgbm_blog_module posts_number=”3″ show_thumbnail=”off” show_author=”off” show_pagination=”off” show_more=”on” space_between=”42px” equal_height=”on” container_margin=”||||false|false” container_padding=”||||false|false” article_margin=”||||false|false” article_padding=”||||false|false” content_margin=”||||false|false” content_padding=”30px|30px|30px|30px|true|true” meta_bottom_padding=”||||false|false” button_wrapper_margin=”20px||||false|false” category_location=”top” date_margin=”10px||10px||true|false” module_class=”zdm-blog-grid” _builder_version=”4.21.0″ _module_preset=”default” title_text_color=”#17374E” title_line_height=”1.1em” read_more_font=”||||||||” read_more_text_color=”#009ACA” read_more_font_size=”16px” date_font=”|600|||||||” date_text_color=”#2C6893″ date_font_size=”13px” category_font=”|600||on|||||” category_text_color=”#2C6893″ category_font_size=”13px” category_letter_spacing=”1px” background_color=”#FFFFFF” border_width_all_post_item=”2px” border_color_all_post_item=”gcid-f0845e9b-066a-4b8b-a6b5-20f5259bbdfd” border_style_all_post_item=”dashed” global_colors_info=”{%22gcid-f0845e9b-066a-4b8b-a6b5-20f5259bbdfd%22:%91%22border_color_all_post_item%22%93}” read_more_text_color__hover_enabled=”on|desktop” read_more_text_color__hover=”#16B591″ title_text_color__hover_enabled=”on|desktop” title_text_color__hover=”#2C6893″ category_text_color__hover_enabled=”on|desktop” category_text_color__hover=”#2C6893″][/dgbm_blog_module]